Literature DB >> 20811551

Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA.

J Curtis Nickel1, Akira Furuta, Michael B Chancellor, Claus G Roehrborn, Dean G Assimos, Ellen Shapiro, Michael K Brawer.   

Abstract

Keywords:  Autologous muscle-derived cells; Botulinum toxin; Escherichia coli; Nocturia; PRX3.02; Prostate-specific antigen; Prostatic urethral lift; Shock wave lithotripsy; Synthetic mesh sling; Transrectal ultrasound prostate; Uropsis

Year:  2010        PMID： 20811551      PMCID： PMC2931291     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  18 in total

1.  Does the rate of extracorporeal shock wave delivery affect stone fragmentation?

Authors:  A Greenstein; H Matzkin
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

2.  Shockwave frequency affects fragmentation in a kidney stone model.

Authors:  M J Weir; N Tariq; R J Honey
Journal:  J Endourol       Date:  2000-09       Impact factor: 2.942

3.  Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results.

Authors:  M B Chancellor; A Atan; D A Rivas; T Watanabe; H L Tai; H Kumon
Journal:  Tech Urol       Date:  1999-12

Review 4.  Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxin.

Authors:  Abdel-Rahmène Azzouzi; Marc Fourmarier; Francois Desgrandchamps; Charles Ballereau; Christian Saussine; Olivier Haillot; Bertrand Lukacs; Marian Devonec; Alexandre de la Taille
Journal:  World J Urol       Date:  2006-05-18       Impact factor: 4.226

5.  Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.

Authors:  Michael Marberger; Claus G Roehrborn; Leonard S Marks; Timothy Wilson; Roger S Rittmaster
Journal:  J Clin Endocrinol Metab       Date:  2006-01-24       Impact factor: 5.958

6.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

7.  Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group.

Authors:  Anna E Teeter; Joseph C Presti; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Urology       Date:  2013-07       Impact factor: 2.649

8.  Shock wave lithotripsy: a randomized, double-blind trial to compare immediate versus delayed voltage escalation.

Authors:  R John D'A Honey; A Andrew Ray; Daniela Ghiculete; Kenneth T Pace
Journal:  Urology       Date:  2009-11-06       Impact factor: 2.649

9.  The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.

Authors:  Theodore M Johnson; Pamela K Burrows; John W Kusek; Leroy M Nyberg; J Lisa Tenover; Herbert Lepor; Claus G Roehrborn
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

Review 10.  Treatment protocols to reduce renal injury during shock wave lithotripsy.

Authors:  James A McAteer; Andrew P Evan; James C Williams; James E Lingeman
Journal:  Curr Opin Urol       Date:  2009-03       Impact factor: 2.309
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.